C2N Diagnostics
MO - St. Louis
Diagnostics1 H-1B visas (FY2023)Focus: Diagnostics & Therapeutics for Alzheimer's
C2N Diagnostics is a life sciences company focused on Diagnostics & Therapeutics for Alzheimer's.
Neurology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
PrecivityAD blood test
Alzheimer DiseaseClinical Trials (1)
NCT05477056Quality Improvement PrecivityAD Clinician Survey (QUIP I)
N/APrecivityAD2
Alzheimer DiseaseClinical Trials (1)
NCT06025877Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey
N/APrecivityAD2 - Early Testing
Alzheimers DiseaseClinical Trials (1)
NCT06856681Clinical Utility of Early vs. Late Blood Biomarker Testing for Alzheimer's Disease
N/ADigital MoCA
Mild Cognitive ImpairmentClinical Trials (1)
NCT07041450Screening for Anti-amyloid Treatment Eligibility Using Digital Cognition and Blood-based Biomarkers
N/ASingle dose C2N-8E12
Progressive Supranuclear PalsyClinical Trials (1)
NCT02494024Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Phase 1Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 5 clinical trials
Top TAs: Neurology
H-1B (2023): 1 approval
Publications: 25 in PubMed
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub